Home/Filings/4/0001477449-23-000107
4//SEC Filing

Jensen Claus Torp 4

Accession 0001477449-23-000107

CIK 0001477449other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:08 PM ET

Size

10.6 KB

Accession

0001477449-23-000107

Insider Transaction Report

Form 4
Period: 2023-12-01
Jensen Claus Torp
Chief Innovation Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-012,04312,264 total
    Common Stock (2,043 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-01+2,04320,703 total
  • Exercise/Conversion

    Common Stock

    2023-12-01+2,80718,660 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-012,80714,038 total
    Common Stock (2,807 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F3]On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001857993

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:08 PM ET
Size
10.6 KB